Optimizing the germfree mouse model for in vivo evaluation of oral Vibrio cholerae vaccine and vector strains

被引:19
作者
Crean, TI
John, M
Calderwood, SB
Ryan, ET [1 ]
机构
[1] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA
关键词
D O I
10.1128/IAI.68.2.977-981.2000
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The germfree mouse model of Vibrio cholerae infection can be used to judge immune responses to V. cholerae vaccine and vector strains, In the original model, a single oral inoculation was administered on day 0, a booster oral inoculation was administered on day 14, and immune responses were analyzed with samples collected on day 28, Unfortunately, immune responses in this model frequently were low level, and interanimal variability occurred. In order to improve this model, we evaluated various primary and booster V. cholerae inoculation schedules. The most prominent systemic and mucosal antibody responses were measured in mice that received a multiple primary inoculation series on days 0, 2, 4, and 6 and booster inoculations on days 28 and 42, These modifications result in improved preliminary evaluation of ii. cholerae vaccine and vector strains in mice.
引用
收藏
页码:977 / 981
页数:5
相关论文
共 21 条
[1]   USE OF THE VIBRIO-CHOLERAE IRGA GENE AS A LOCUS FOR INSERTION AND EXPRESSION OF HETEROLOGOUS ANTIGENS IN CHOLERA VACCINE STRAINS [J].
BUTTERTON, JR ;
BOYKO, SA ;
CALDERWOOD, SB .
VACCINE, 1993, 11 (13) :1327-1335
[2]   Development of a germfree mouse model of Vibrio cholerae infection [J].
Butterton, JR ;
Ryan, ET ;
Shahin, RA ;
Calderwood, SB .
INFECTION AND IMMUNITY, 1996, 64 (10) :4373-4377
[3]   Coexpression of the B subunit of Shiga toxin 1 and EaeA from enterohemorrhagic Escherichia coli in Vibrio cholerae vaccine strains [J].
Butterton, JR ;
Ryan, ET ;
Acheson, DWK ;
Calderwood, SB .
INFECTION AND IMMUNITY, 1997, 65 (06) :2127-2135
[4]   SUCCESSFUL COLONIZATION AND IMMUNIZATION OF ADULT-RABBITS BY ORAL INOCULATION WITH VIBRIO-CHOLERAE-O1 [J].
CRAY, WC ;
TOKUNAGA, E ;
PIERCE, NF .
INFECTION AND IMMUNITY, 1983, 41 (02) :735-741
[5]   COMPARATIVE EFFICACY OF 2, 3, OR 4 DOSES OF TY21A LIVE ORAL TYPHOID VACCINE IN ENTERIC-COATED CAPSULES - A FIELD TRIAL IN AN ENDEMIC AREA [J].
FERRECCIO, C ;
LEVINE, MM ;
RODRIGUEZ, H ;
CONTRERAS, R .
JOURNAL OF INFECTIOUS DISEASES, 1989, 159 (04) :766-769
[6]   IDENTIFICATION OF AN IRON-REGULATED VIRULENCE DETERMINANT IN VIBRIO-CHOLERAE, USING TNPHOA MUTAGENESIS [J].
GOLDBERG, MB ;
DIRITA, VJ ;
CALDERWOOD, SB .
INFECTION AND IMMUNITY, 1990, 58 (01) :55-60
[7]  
JOHN M, IN PRESS INFECT IMMU
[8]   Distinct roles of an alternative sigma factor during both free-swimming and colonizing phases of the Vibrio cholerae pathogenic cycle [J].
Klose, KE ;
Mekalanos, JJ .
MOLECULAR MICROBIOLOGY, 1998, 28 (03) :501-520
[9]  
LEVINE M M, 1988, Lancet, V2, P467
[10]   DURATION OF INFECTION-DERIVED IMMUNITY TO CHOLERA [J].
LEVINE, MM ;
BLACK, RE ;
CLEMENTS, ML ;
CISNEROS, L ;
NALIN, DR ;
YOUNG, CR .
JOURNAL OF INFECTIOUS DISEASES, 1981, 143 (06) :818-820